ClinicalTrials.gg
Drug

Gefitinib clinical trials

Also written Iressa and ZD1839.

studies test it
231
open now
6
in phase 3
31
first study started
2000

How each study uses Gefitinib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Gefitinib studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
5 May 2003 · IRESSA · NDA 021399 (FDA, Drugs@FDA)
European Union
24 Jun 2009 · Iressa · EMEA/H/C/001016 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Gefitinib
159
Gefitinib (Iressa)
6
Iressa (Gefitinib)
5
ZD1839 (IRESSA)
4
Gefitinib Tablet 250mg of Hunan Kelun
2

Brand

Iressa
87

Development codes

ZD1839
52

Studies by the year they started

228 studies that test it; most in 2004 (42)

Studies that test Gefitinib, by start year
YearStudies
20002
200117
200222
200338
200442
200522
20068
20075
20085
20099
20102
20115
20129
20135
20148
20156
20166
20174
20185
20204
20241
20263

Who runs them

Industry 61 · Other 170

AstraZeneca (49) · National Cancer Institute (NCI) (22) · M.D. Anderson Cancer Center (5) · European Organisation for Research and Treatment of Cancer - EORTC (5) · University of Chicago (4) · Fudan University (4) · Samsung Medical Center (4) · Memorial Sloan Kettering Cancer Center (4)

Often tested with

Tested in the same studies.

Cisplatin (15) · Docetaxel (9) · Pemetrexed (8) · Carboplatin (5) · Erlotinib (5) · Gemcitabine (5) · Fluorouracil (5) · Paclitaxel (4)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 2 phase 3 studies under way

Gefitinib is the comparator. A study of two new drugs counts under both.

  • 1ASK-120067 · Jiangsu Aosaikang Pharmaceutical Co., Ltd.
  • 1Aflutinib · Jiangsu Aosaikang Pharmaceutical Co., Ltd.
Reaching primary completion within a year · 1

Studies that test Gefitinib.

Studies

Open first, then newest update. How each study uses Gefitinib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 231

See all 231 studies that test Gefitinib →

Given beside what is tested · 44 — Gefitinib is usual care or a partner of the new treatment

Showing 20 of 44.

As the comparator · 18 — what is tested is compared with Gefitinib

Codes

What other systems call Gefitinib · ClinicalTrials.gg INT006655

  • MeSH (NLM) D000077156GefitinibConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) S65743JHBSGEFITINIBConfirmed FDA, NLM, Wikidata
  • RxNorm 328134Confirmed FDA, Wikidata
  • Wikidata Q417824gefitinibConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1855GefitinibOne source FDA
  • DrugBank DB00317One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.